Atlas FDA

CONCEPTUS ESSURE SYSTEM FOR PERMANENT BIRTH CONTROL

FDA premarket approval P020014/S035 · decided 2012-03-19

Approval details

PMA number
P020014
Supplement
S035
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
CONCEPTUS ESSURE SYSTEM FOR PERMANENT BIRTH CONTROL
Generic name
Transcervical contraceptive tubal occlusion device
Applicant
Bayer Pharma AG
Date received
2011-04-14
Decision date
2012-03-19
Days to decision
340 days
Decision code
APPR
Product code
HHS
Advisory committee
Obstetrics/Gynecology
Expedited review
No
Location
Berlin
Statement
APPROVAL FOR REVISED PROFESSIONAL AND PATIENT LABELING.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.